Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.

Corry RJ, Egidi MF, Shapiro R, Sugitani A, Gritsch HA, Jordan ML, Dodson SF, Vivas CA, Scantlebury VP, Rao AS, Fung JJ, Starzl TE. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. Transplant Proc. 1998 Mar; 30(2):521.

View in: PubMed

collapse authors with profiles